Disturbances of parathyroid hormone-vitamin D axis in non-cholestatic chronic liver disease: A cross-sectional study

Hepatology International

Volumn 4, Issue 3, 2010, Pages 634-640

  Miroliaee, Arash ^a   Nasiri Toosi, Mohsen ^a   Khalilzadeh, Omid ^a,b   Esteghamati, Alireza ^b   Abdollahi, Alireza ^a   Mazloumi, Mehdi ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Child Pugh score; Cirrhosis; Liver; MELD; Parathyroid hormone; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; LIVER ENZYME; PARATHYROID HORMONE; VITAMIN D;

ADULT; ANEMIA; ARTICLE; AUTOIMMUNE HEPATITIS; BLOOD CLOTTING DISORDER; CALCIUM BLOOD LEVEL; CHRONIC LIVER DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; ENZYME BLOOD LEVEL; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HYPERBILIRUBINEMIA; HYPOALBUMINEMIA; LIVER CIRRHOSIS; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PATIENT CARE; PHOSPHATE BLOOD LEVEL; PREVALENCE; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; THROMBOCYTOPENIA; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM;

EID: 77958107912     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-010-9194-2     Document Type: Article

References (28)

1. HM Pappa E Bern D Kamin RJ Grand 2008 Vitamin D status in gastrointestinal and liver disease Curr Opin Gastroenterol 24 176 183 1:CAS:528:DC%2BD1cXisVeltbk%3D 10.1097/MOG.0b013e3282f4d2f3 18301268 (Pubitemid 351322784)
2. K Tsuneoka Y Tameda K Takase T Nakano 1996 Osteodystrophy in patients with chronic hepatitis and liver cirrhosis J Gastroenterol 31 669 678 1:STN:280:DyaK2s%2FktFOlsA%3D%3D 10.1007/BF02347615 8887033 (Pubitemid 26345533)
3. J George HK Ganesh S Acharya TR Bandgar V Shivane A Karvat, et al. 2009 Bone mineral density and disorders of mineral metabolism in chronic liver disease World J Gastroenterol 15 3516 3522 1:CAS:528:DC%2BD1MXpsF2ru7c%3D 10.3748/wjg.15.3516 19630107
4. FJ Gallego-Rojo JL Gonzalez-Calvin M Munoz-Torres JL Mundi R Fernandez-Perez D Rodrigo-Moreno 1998 Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis Hepatology 28 695 699 1:STN:280:DyaK1cvgtVartQ%3D%3D 10.1002/hep.510280315 9731561
5. WD Leslie CN Bernstein MS Leboff 2003 AGA technical review on osteoporosis in hepatic disorders Gastroenterology 125 941 966 10.1016/S0016-5085(03)01062-X 12949738 (Pubitemid 37070710)
6. N Yenice M Gumrah O Mehtap A Kozan S Turkmen 2006 Assessment of bone metabolism and mineral density in chronic viral hepatitis Turk J Gastroenterol 17 260 266 17205403
7. AT de Albuquerque Taveira MI Fernandes LC Galvao R Sawamura E de Mello Vieira FJ de Paula 2007 Impairment of bone mass development in children with chronic cholestatic liver disease Clin Endocrinol 66 518 523
8. MP Duarte ML Farias HS Coelho LM Mendonca LM Stabnov M Do Carmo d Oliveira, et al. 2001 Calcium-parathyroid hormone-vitamin D axis and metabolic bone disease in chronic viral liver disease J Gastroenterol Hepatol 16 1022 1027 1:CAS:528:DC%2BD3MXotlyltbc%3D 10.1046/j.1440-1746.2001.02561.x 11595067 (Pubitemid 32947145)
9. JN Artaza KC Norris 2009 Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells J Endocrinol 200 207 221 1:CAS:528:DC%2BD1MXjvVOguro%3D 10.1677/JOE-08-0241 19036760
10. S Samuel MD Sitrin 2008 Vitamin D's role in cell proliferation and differentiation Nutr Rev 66 S116 S124 10.1111/j.1753-4887.2008.00094.x 18844838
11. BD Boyan Z Schwartz 2009 1,25-Dihydroxy vitamin D3 is an autocrine regulator of extracellular matrix turnover and growth factor release via ERp60-activated matrix vesicle matrix metalloproteinases Cells Tissues Organs 189 70 74 1:CAS:528:DC%2BD1cXhsVOgsb7L 10.1159/000152916 18765931
12. RN Pugh IM Murray-Lyon JL Dawson MC Pietroni R Williams 1973 Transection of the oesophagus for bleeding oesophageal varices Br J Surg 60 646 649 1:STN:280:DyaE3s3jsVWqsw%3D%3D 10.1002/bjs.1800600817 4541913
13. PS Kamath RH Wiesner M Malinchoc W Kremers TM Therneau CL Kosberg, et al. 2001 A model to predict survival in patients with end-stage liver disease Hepatology 33 464 470 1:STN:280:DC%2BD3M7kvVOqug%3D%3D 10.1053/jhep.2001.22172 11172350 (Pubitemid 32119037)
14. B Dawson-Hughes RP Heaney MF Holick P Lips PJ Meunier R Vieth 2005 Estimates of optimal vitamin D status Osteoporos Int 16 713 716 1:CAS:528:DC%2BD2MXls1ahurk%3D 10.1007/s00198-005-1867-7 15776217 (Pubitemid 40933586)
15. S Ormarsdottir O Ljunggren H Mallmin K Michaelsson L Loof 2002 Increased rate of bone loss at the femoral neck in patients with chronic liver disease Eur J Gastroenterol Hepatol 14 43 48 10.1097/00042737-200201000-00008 11782574 (Pubitemid 34112160)
16. CC Chen SS Wang FS Jeng SD Lee 1996 Metabolic bone disease of liver cirrhosis: is it parallel to the clinical severity of cirrhosis? J Gastroenterol Hepatol 11 417 421 1:STN:280:DyaK28zjvVKgtQ%3D%3D 10.1111/j.1440-1746.1996. tb00284.x 8743912
17. S Masuda T Okano K Osawa M Shinjo T Suematsu T Kobayashi 1989 Concentrations of vitamin D-binding protein and vitamin D metabolites in plasma of patients with liver cirrhosis J Nutr Sci Vitaminol 35 225 234 1:STN:280:DyaK3c%2FmtlyltA%3D%3D 2585144
18. S Shiomi K Masaki D Habu T Takeda S Nishiguchi T Kuroki, et al. 1999 Calcitriol for bone disease in patients with cirrhosis of the liver J Gastroenterol Hepatol 14 547 552 1:CAS:528:DyaK1MXktVeitrs%3D 10.1046/j.1440-1746.1999.01913.x 10385063 (Pubitemid 29281876)
19. AJ Sanchez J Aranda-Michel 2006 Liver disease and osteoporosis Nutr Clin Pract 21 273 278 10.1177/0115426506021003273 16772544
20. A Monegal M Navasa N Guanabens P Peris F Pons MJ Martinez de Osaba, et al. 1997 Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation Calcif Tissue Int 60 148 154 1:CAS:528:DyaK2sXhtVagsrk%3D 10.1007/s002239900205 9056162 (Pubitemid 27058703)
21. XL Bai TB Liang LH Wu DL Li L Geng WL Wang, et al. 2007 Elevation of intact parathyroid hormone level is a risk factor for low bone mineral density in pretransplant patients with liver diseases Transplant Proc 39 3182 3185 1:CAS:528:DC%2BD2sXhsVentbnJ 10.1016/j.transproceed.2007.06.093 18089348 (Pubitemid 350258651)
22. S Uretmen M Gol D Cimrin E Irmak 2005 Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women Eur J Obstet Gynecol Reprod Biol 123 67 71 1:CAS:528:DC%2BD2MXhtFyktrbE 10.1016/j.ejogrb.2005.06.025 16051419 (Pubitemid 41563096)
23. L Fisher A Fisher 2007 Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease Clin Gastroenterol Hepatol 5 513 520 1:CAS:528:DC%2BD2sXlsFWhsbs%3D 10.1016/j.cgh.2006.10.015 17222588 (Pubitemid 46575356)
24. L Adorini 2009 Vitamin D receptor polymorphisms in primary biliary cirrhosis: a functional connection? J Hepatol 50 1071 1073 1:CAS:528: DC%2BD1MXlslWnu7Y%3D 10.1016/j.jhep.2009.03.005 19398232
25. G Fattovich G Giustina F Degos F Tremolada G Diodati P Almasio, et al. 1997 Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients Gastroenterology 112 463 472 1:STN:280:DyaK2s7ns1Olsw%3D%3D 10.1053/gast.1997.v112.pm9024300 9024300 (Pubitemid 27078833)
26. JR Phillips P Angulo T Petterson KD Lindor 2001 Fat-soluble vitamin levels in patients with primary biliary cirrhosis Am J Gastroenterol 96 2745 2750 1:CAS:528:DC%2BD3MXns1ygsLc%3D 10.1111/j.1572-0241.2001.04134.x 11569705
27. SW Coppack MD Jensen JM Miles 1994 In vivo regulation of lipolysis in humans J Lipid Res 35 177 193 1:CAS:528:DyaK2cXhsF2nuro%3D 8169522
28. J Collier 2007 Bone disorders in chronic liver disease Hepatology 46 1271 1278 1:CAS:528:DC%2BD2sXht1aksrvK 10.1002/hep.21852 17886334 (Pubitemid 350144791)